glp 1 drugs hair loss Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become increasingly popular for the management of obesity and diabetes. You know these by names like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda GLP-1 Hair Loss: Ozempic Shedding

The primary outcome was the incidence of overall thyroid disorders, and the secondary outcomes included the incidence of goiter, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass, and thyroid cancer

Quick shipping but a little confusing with so many syringes

Hartman ML, Loomba R, Lawitz EJ, et al

Conclusion A new drug named tirzepatide has been approved to treat T2DM, and it is expected to be approved for weight loss by activating both GLP-1 and GIP receptors through a unique mechanism

Mounjaro generally offers the strongest weight-loss results

The dosage is carefully escalated over time to improve tolerability and reduce the risk of gastrointestinal side effects